SQZ Biotechnologies Co
SQZB evidence brief
What we can confirm
- BioSniper Score:
- 6.0 / 10
- Market Cap:
- $708K
- Lead Asset:
- sqz-aac-hpv (Phase 1)
What it means
What to watch
Prepared research question
What matters most for SQZB—catalysts, financial risk and supporting evidence?
Traceable citations · Unknowns marked
BioSniper Score
Based on 2 of 6 signals
Limited data coverage
Market Cap
$708K
Cash Runway
—
Lead Asset
sqz-aac-hpv (Phase 1)
Next Catalyst
—
Tracking 3 pipeline candidates for SQZ Biotechnologies Co.
Run SQZ Biotechnologies Co through your own thesis
Use the pipeline, catalyst, financial, FDA, and market facts on this page as inputs to a protocol you control.
Your protocol can:
- Turn available SQZ Biotechnologies Co facts into screen rules or deeper checks
- Show cited findings, blockers, and unresolved evidence together
- Save the logic and rerun it as the company evidence changes
Score breakdownBased on 2 of 6 signals · derived from public data
Cash runway data unavailable
Financial health data unavailable
Lead: Phase 1/Phase 2
3 candidates
No upcoming catalysts tracked
No insider transactions in the last 180 days
Pipeline
Financials
Institutional Holdings
Source: SEC Form 13F · as of Sep 2023Institutional holders
1
Total value held
$144
| Holder | Shares | Value |
|---|---|---|
| barclays plc | 1,794 | $144 |
Short Interest
as of May 22, 2026- % of float
- 3.0%
- Days to cover
- 27.3
- Shares short
- 811,150
- Daily short volume
- -
Short percent of float and days-to-cover reflect reported short positioning. Daily short volume is the exchange-reported short share of a single day's trading volume and is noisier. See the most-shorted biotech ranking →
SQZB short interestGovernance
Frequently asked questions
What is SQZ Biotechnologies Co's lead drug candidate?
SQZ Biotechnologies Co's most advanced tracked candidate is sqz-aac-hpv (Phase 1) for HPV16+ advanced or metastatic tumors.
Who is the CEO of SQZ Biotechnologies Co?
Howard Bernstein, M.D. is the chief executive officer of SQZ Biotechnologies Co (SQZB).
Where is SQZ Biotechnologies Co headquartered?
SQZ Biotechnologies Co (SQZB) is headquartered in Watertown, MA, United States.
What therapeutic areas does SQZ Biotechnologies Co focus on?
SQZ Biotechnologies Co develops therapies across Oncology, Immunology, Infectious Disease.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.